Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

Presentation

Chronic Spontaneous Urticaria: Epidemiology, Diagnosis, and Management

Description

The lecture explains that chronic spontaneous urticaria (CSU) is a common, chronic skin disease that is much easier to manage than many clinicians may think because effective treatments and clear stepwise algorithms exist. It distinguishes acute urticaria, which lasts less than six weeks and often has an identifiable trigger such as stress, viral illness, or allergy, from chronic urticaria, which persists for at least six weeks and includes both CSU and chronic inducible urticaria. CSU has no clear external trigger, can look like acute hives, and is diagnosed primarily by history and duration rather than morphology. Common inducible forms include dermatographism, cold urticaria, and cholinergic urticaria, each diagnosed by specific provocation tests and managed with avoidance or antihistamines. CSU affects about 1 to 2% of people worldwide, is twice as common in women, often begins between ages 20 and 40, and usually lasts years, creating significant burdens including sleep disruption, anxiety, depression, social withdrawal, and work impairment. Routine biopsy and allergy testing are not recommended; evaluation is mainly clinical, with selective labs such as CBC, CMP, TSH, anti-TPO, and sometimes H. pylori testing. The talk also emphasizes distinguishing CSU from urticarial vasculitis, which features lesions lasting more than 24 hours plus systemic symptoms and may require biopsy and immunosuppressive treatment. Angioedema is discussed as a common feature of CSU, but it does not imply anaphylaxis risk in this context. Finally, the lecture reviews severity measures such as UAS7 and the urticaria control test, which help track symptoms and treatment response.

View more

Conclusions

Chronic spontaneous urticaria is a common, chronic condition that is often more manageable than it first appears because effective treatment algorithms are available.
The key clinical distinction in urticaria is duration and trigger history, not lesion appearance, since acute, chronic spontaneous, and inducible urticarias can look similar.
Most chronic urticaria workups should be minimal: the diagnosis is clinical, routine biopsy is usually unnecessary, and broad allergy testing is not recommended.
Targeted basic labs such as CBC, CMP, TSH, anti-TPO, and sometimes H. pylori testing may be reasonable, but extensive testing rarely changes management.
Chronic urticaria has a major quality-of-life burden, including sleep disruption, anxiety, depression, and social or occupational impairment.
Chronic urticaria is usually a long-term disease lasting years, so patients need realistic expectations and sustained treatment strategies rather than short-term reassurance alone.
Cold urticaria, dermatographism, and cholinergic urticaria are important inducible subtypes that can often be confirmed with simple bedside provocation tests.
Angioedema is common in chronic spontaneous urticaria, but it is not the same as anaphylaxis and does not by itself imply anaphylactic risk.
Urticarial vasculitis should be suspected when wheals last longer than 24 hours with systemic symptoms, because it is a different disorder requiring biopsy and immunosuppressive treatment.
Disease severity in CSU is best tracked with validated tools such as the UAS7 and urticaria control test, which help guide treatment decisions and monitor response.

Zuberbier T et al. JID 2001.
Wong et al., JACI 2025